$80K — $100K *
At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our 39,000 employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.
At Lilly, we serve an extraordinary purpose. We make a difference for people around the globe by discovering, developing and delivering medicines that help them live longer, healthier, more active lives. Not only do we deliver breakthrough medications, but you also can count on us to develop creative solutions to support communities through philanthropy and volunteerism. Come join our family of dedicated employees!
Reporting to the Senior Director, Diabetes and Complications Therapeutic Area (DCTA), the successful candidate will contribute to the discovery and early development of breakthrough therapies in diabetes with focus on beta-cell regeneration and islet cell therapy. Are you passionate about science and the desire to make a difference in the lives of our people living with diabetes? Lilly is a leader in diabetes research working to make the next wave of inventive therapies for diabetes happen. Consider joining Lilly to make a positive impact on the lives of our patients.
Do you have experience managing data-driven research from project inception to clinical trial design? Defining and leading projects focused on innovative therapies for type 1 and type 2 diabetes at the intersection of immunology and beta-cell biology will be a key responsibility. This position is in a laboratory that uses an iPSC-derived islet platform to impact Lilly’s breakthrough therapeutic programs in endogenous beta-cell regeneration, islet cell replacement and immunomodulation. Working closely with bioinformatics scientists, in vitro and in vivo pharmacologists, chemists, manufacturing scientists and clinicians, you will identify and validate new targets, contribute to and influence drug discovery efforts, and support islet-cell therapy efforts across different stages in the portfolio.
Needed in this role is solid understanding of islet cell developmental biology and function, hands-on-experience with iPSC-derived platforms, deep knowledge of beta-cell physiology and a desire to be at the forefront of scientific innovation. Key components of the role are informing scientific direction, initiating and progressing efforts with focus on scientific rigor and effectiveness, and building and maintaining state-of-the art preclinical expertise. An additional opportunity of this role will be to identify and lead collaborations with academic and biotech partners that seek to complement and enhance the internal efforts.
Valid through: 6/24/2021
$80K — $100K *
7 days ago
$80K — $100K *